Zhang; Xiao-kun
Patent Applications and Registrations
Patent applications and USPTO patent grants for Zhang; Xiao-kun.The latest application filed is for "methods and compositions related to retinoid receptor-selective pathway".
- Zhang; Xiao-kun - San Diego CA
- ZHANG; Xiao-kun - La Jolla CA
| Patent | Date |
|---|---|
| Methods and compositions related to retinoid receptor-selective pathway Grant 10,087,156 - Zhang , et al. October 2, 2 | 2018-10-02 |
| Methods And Compositions Related To Retinoid Receptor-selective Pathway App 20170313668 - ZHANG; Xiao-kun ; et al. | 2017-11-02 |
| Methods and compositions related to a retinoid receptor-selective pathway Grant 9,611,235 - Zhang , et al. April 4, 2 | 2017-04-04 |
| Methods And Compositions For Treating Cancer App 20160340324 - SU; Ying ; et al. | 2016-11-24 |
| Methods And Compositions Related To A Retinoid Receptor-selective Pathway App 20150266842 - Zhang; Xiao-kun ; et al. | 2015-09-24 |
| Identification Of Compounds That Regulate Apoptosis App 20130157260 - Satterthwait; Arnold ; et al. | 2013-06-20 |
| Conversion of apoptotic proteins Grant 8,273,705 - Reed , et al. September 25, 2 | 2012-09-25 |
| Cytoplasmic activity of retinoid X receptor and its regulation by ligands and dimerization Grant 8,105,798 - Zhang , et al. January 31, 2 | 2012-01-31 |
| Induction of apoptosis in cancer cells Grant RE42,700 - Dawson , et al. September 13, 2 | 2011-09-13 |
| Methods Of Regulating Apoptosis App 20100292145 - Satterthwait; Arnold ; et al. | 2010-11-18 |
| Compounds that regulate apoptosis Grant 7,745,574 - Satterthwait , et al. June 29, 2 | 2010-06-29 |
| Conversion Of Apoptotic Proteins App 20090215984 - Reed; John C. ; et al. | 2009-08-27 |
| Conversion of apoptotic proteins Grant 7,491,700 - Reed , et al. February 17, 2 | 2009-02-17 |
| Conversion Of Apoptotic Proteins App 20070117753 - Reed; John C. ; et al. | 2007-05-24 |
| Compounds that regulate apoptosis App 20070054863 - Satterthwait; Arnold ; et al. | 2007-03-08 |
| Conversion of apoptotic proteins Grant 7,176,277 - Reed , et al. February 13, 2 | 2007-02-13 |
| Conversion of apoptotic proteins App 20060193864 - Reed; John C. ; et al. | 2006-08-31 |
| Heterodimers of retinoid X receptors (RXRS) and other steroid hormone receptors Grant 7,098,310 - Pfahl , et al. August 29, 2 | 2006-08-29 |
| Induction of apoptosis in cancer cells Grant 7,053,071 - Dawson , et al. May 30, 2 | 2006-05-30 |
| Heterodimers of retinoid X receptors (RXRS) and other steroid hormone receptors Grant 7,026,125 - Pfahl , et al. April 11, 2 | 2006-04-11 |
| Conversion of apoptotic proteins Grant 6,994,979 - Reed , et al. February 7, 2 | 2006-02-07 |
| Cytoplasmic activity of retinoid X receptor and its regualtion by ligands and dimerization App 20050054008 - Zhang, Xiao-kun ; et al. | 2005-03-10 |
| Conversion of apoptotic proteins App 20040220097 - Reed, John C. ; et al. | 2004-11-04 |
| Induction of apoptosis in cancer cells App 20030176506 - Dawson, Marcia J. ; et al. | 2003-09-18 |
| RXR homodimer formation Grant 5,824,484 - Pfahl , et al. October 20, 1 | 1998-10-20 |
| Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors Grant 5,466,861 - Dawson , et al. November 14, 1 | 1995-11-14 |
| NCAGE Code | 4CKY8 | ZHANG XIAO-KUN |
| CAGE Code | 4CKY8 | ZHANG, XIAO-KUN |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 